Kemira's organic revenue growth and profitability improvement continues Content: - Where water meets chemistry - Q2/2013 - Outlook - Appendix

1. January-June
2013
Kemira Interim report
Wolfgang Büchele, President and CEO | July 23, 2013

2. Agenda
Kemira Interim report January-June 2013
Where water meets chemistryTM
Q2 2013
Outlook
Appendix

3. Focus on paper,
oil & gas, mining and
water treatment
Kemira in the value
chain of WQQM*
Expertise and tailored
combinations of
chemicals
for water-intensive
industries
Improving our
customers’ water,
energy and raw
material efficiency
*) Water Quality and Quantity Management
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 3

4. Strengthening market
position in polymer
product line
Kemira to acquire 3F Chimica
for EUR 85 million
3F revenue is approximately
EUR 75 million, mainly polymer product
line related
Acquisition increases polymer capacity
(2 sites in Europe and 1 in the US)
Closes technology gaps in monomer
and polymer production
Transaction is expected to result
in substantial synergies
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 4

5. Kemira Interim report Q2 2013, Wolfgang Büchele
Accelerating shift to fast growing differentiated products
3F acquisition and the divestment of ChemSolutions formic acid and derivatives product lines would
increase the share of Kemira differentiated product line revenue from 40% to 45%
Differentiated product lines Commodity product lines
%-of total
revenue in
2012
Polymers Sizing and
strength
Defoamers,
dispersants,
biocides and
other process
chemicals
Coagulants Bleaching
chemicals
Formic acid
and derivatives
Miscellaneous
commodity
products*
Paper 10% 20% 20% 5% 25% - 20%
M&I 20% - 5% 65% - - 10%
O&M 50% - 20% 5% - - 25%
Chem-
Solutions
- - - - - 80% 20%
Kemira 20% 10% 10% 25% 10% 10% 15%
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 5
*) Mainly sodium percarbonate, colorants, acrylamide, inorganic salts and acids as well as caustic soda

6. • Revenue EUR 569 million (562 in Q2 2012), +1%
– Organic revenue growth +4%, driven by increased sales volumes
• Operative EBIT EUR 40 million (36), +11%
– Operative EBIT margin 7.0% (6.4%)
– ”Fit for Growth” savings EUR 10 million
• Non-recurring items impacting EBIT amounted to EUR 27 million
– Thereof Vaasa site closure (15), Business Service Center (6) and
”Fit for Growth” related restructuring charges (3)
• Net working capital (ratio) of revenue reduced to 11.3%
(12.8% in 2012)
– Lower inventories and higher payables
• Cash flow after investing activities increased vs Q2 2012*
Continued organic revenue growth and improved profitability
April-June 2013
6
*) Excluding EUR 5.3 million dividends and EUR 27.3 million paid-in-capital from JV Sachtleben in Q2 2012
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele

7. Accelerating organic growth driven
by increased sales volumes
Kemira Group revenue growth trend
-15%
-10%
-5%
0%
5%
10%
15%
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
2009 2010 2011 2012 2013
Organic growth Currency Acquisitions Divestments Total growth
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 7

8. Sales volumes increased in all segments
Kemira Group operative EBIT bridge, EUR million
Q2 2012 Sales volumes Sales prices Variable costs Fixed costs Currency impact Others, incl.
acquisitions and
divestments
Q2 2013
36.0 10.8 40.0-0.6-0.7-4.9 0.4 -1.0
Including one off
consultancy and
advisory expenses
of EUR 3 million
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 8

9. Restructuring charges related to ”Fit for Growth” booked,
all measures under implementation
• ”Fit for Growth” cost savings impact was EUR 10 million in Q2 2013
(full run rate EUR 15 million per quarter)
• Full run rate expected to be achieved in Q4 2013
EUR 60 million
cost savings in 2014
1. Redundancies and leaner organization:
EUR 30 million (Headcount reduced by 517)
2. Manufacturing network consolidation:
EUR 21 million (12 site and 2 production plant
closures decided)
3. Leaner operation:
EUR 9 million (# SKU’s reduced by 45%)
Restructuring charges amounted to
EUR 76 million (85)
Reported between Q3 2012 – Q2 2013:
• EUR 46 million cash cost,
mainly for severance payments
• EUR 30 million, asset write-downs
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 9

10. Operative EBIT increased more year-on-year
in Q2 compared to Q1
• Full run rate of
”Fit for Growth” savings
expected in Q4 2013
• Vaasa process chemical
site closure to bring
EUR 5 million and
Business Service Center
EUR 10 million additional
annualized cost savings
• 3F acquisition expected
to result in substantial
synergies in raw material,
logistics and other fixed
costs in 2014
39
36
44
27
33
30
3
7
9
10
545
550
555
560
565
570
575
0
5
10
15
20
25
30
35
40
45
50
Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013
Underlying operative EBIT "Fit for Growth" savings Revenue
EUR million
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 10

11. Paper organic growth was 7% in Q2 2013
• Strong sales volume
growth in Sizing, Polymers,
and other differentiated
process chemicals
• Pulp chemical sales
volumes grew, especially
in EMEA and SA
• Hydrogen peroxide
capacity increased by 65%
in Fray Bentos, Uruguay
to serve growing pulp
production in the region
*) Divestments (FWA and Maitland hydrogen peroxide), exited businesses (Siilinjärvi calcium sulphate) and transferred businesses (Sodium percarbonate) are excluded
0
200
400
600
800
1,000
1,200
2009 2010 2011 2012 1-6 2012 1-6 2013
Commodity products Differentiated products
CAGR:+12%
CAGR:+5%
Paper segment revenue*, EUR million
760
873
907
965
524497
+6%
Share of revenues
Packaging & Board 26%
Tissue & Specialties 6%
Printing & Writing 22%
Pulp 47%
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 11

12. Profitable growth accelerated in Paper
April-June 2013
Revenue increased by 6% to
EUR 265 million (249)
• EMEA revenue increased more than 10% driven by
sales volume growth in all main product lines
• Sales prices decreased slightly
• Currency exchange -1%
EUR million Q2/2013 Q2/2012 % 1-6/2013 1-6/2012 % 2012
Revenue 265 249 6 524 497 5 1,006
Operative EBIT 19.5 16.1 21 39.2 34.9 12 75.3
Operative EBIT, % 7.4 6.5 - 7.5 7.0 - 7.5
Cash flow 18 10 80 48 9 433 8
Operative EBIT increased 21% to
EUR 19.5 million (16.1)
• Organic revenue growth
• Higher sales and marketing expenses compensated by
”Fit for Growth” savings
• Operative EBIT margin increased to 7.4% (6.5%)
Strong cash flow
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 12

13. 9.2%
7.1%
5.7%
7.1%
0
150
300
450
600
750
2010 2011 2012 YTD 2013
Municipal & Industrial profitability has started to turn around
• Sales volumes growth in
all the main product lines
• Increased coagulant sales
prices in SA
• ”Fit for Growth” savings
were EUR 5 million in Q2
2013
Coagulants Operative EBIT %
Antiscalants, biocides, defoamers, miscellaneous commodity chemicals
Polymers
644
665 687
343
M&I revenue and operative EBIT-% EUR million
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 13

14. Profitable growth in Municipal & Industrial
April-June 2013
Revenue increased 2% to
EUR 178 million (174)
• Revenues increased in all regions, except APAC
• Currency exchange -1%
EUR million Q2/2013 Q2/2012 % 1-6/2013 1-6/2012 % 2012
Revenue 178 174 2 343 335 2 687
Operative EBIT 15.9 12.0 33 24.5 17.7 38 39.2
Operative EBIT, % 8.9 6.9 - 7.1 5.3 - 5.7
Cash flow 5 -3 - 5 4 25 39
Operative EBIT increased 33% to
EUR 15.9 million (12.0)
• Increased sales prices and sales volumes, as well as
lower fixed costs
• Higher variable costs due to increased propylene
based raw material prices during Q1 2013
• Operative EBIT margin increased to 8.9% (6.9%)
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 14

15. Differentiated product line sales volumes continued
to recover in Oil & Mining
• Polymer sales volumes
in NAFTA increased more
than 20% year-on-year in
Q2 2013
• Oil & Mining differentiated
product lines revenue grew
7% in Q2 2013 compared
to Q1 2013 211
235 247
61
65
0
50
100
150
200
250
2010 2011 2012 YTD 2013
Differentiated product lines revenue, EUR million
CAGR: 9%
Q2
Q1
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 15
+7%

16. Oil & Mining sales volumes increased
April-June 2013
Revenue decreased 5% to
EUR 79.9 million (84.5)
• -4% impact related to exiting from low margin products
as communicated earlier (full impact of EUR 10 million
will be realized by the end of 2013, YTD 2013 impact
EUR 7 million)
• Sales volumes increased for the first time in
six quarters
• Sales prices declined
EUR million Q2/2013 Q2/2012 % 1-6/2013 1-6/2012 % 2012
Revenue 79.9 84.5 -5 156 170 -8 321
Operative EBIT 3.5 7.2 -51 8.6 15.5 -45 25.9
Operative EBIT, % 4.4 8.5 - 5.5 9.1 - 8.1
Cash flow -8 1 - -10 -18 - -5
Operative EBIT decreased to
EUR 3.5 million (7.2)
• Price pressure in the market
• Increased R&D spend to accelerate
the differentiation
• Variable costs started to come down towards
the end of the quarter
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 16

17. Investing to meet customer challenges
Challenges Oil & Mining applications
Process efficiency/Increased energy demand Horsepower Reduction in Wet/Dry Shale Hydraulic
Fracturing , Oil Sands, Cementing
Declining reserves Pelletization, Flotation,
EOR
Water scarcity Water Reuse, Scale and Microbiological Control, Shale
Water Management
Environmental concerns Tailings Management, Shale Water Reuse,
Contaminants Removal
Key differentiated products Polymers, Biocides, Defoamers, Scale Inhibitors,
Dispersants
Targeting innovation sales* of EUR 100 million in 2016
*) Sales from new products or existing products for new applications launched within the previous 5 years
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 17

18. ChemSolutions revenue was impacted by the food and
pharmaceuticals businesses divestment
April-June 2013
Revenue decreased 16% to
EUR 46 million (55)
• Organic growth 7%, continued strong sales volumes
growth of formic acid and derivatives product lines
• Divestment of food and pharmaceuticals businesses
had -22% impact
EUR million Q2/2013 Q2/2012 % 1-6/2013 1-6/2012 % 2012
Revenue 46 55 -16 107 114 -6 228
Operative EBIT 1.1 0.7 57 9.9 6.5 52 15.1
Operative EBIT, % 2.4 1.3 - 9.2 5.7 - 6.6
Cash flow -4 -2 - 77 13 - 24
Operative EBIT increased 57% to
EUR 1.1 million (0.7)
• Higher sales volumes and lower variable costs
• Strong market pressure on Sodium Percarbonate
product line
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 18

19. Key figures and ratios
EUR million (except ratios) 4-6/2013 4-6/2012 % 1-6/2013 1-6/2012 % 2012
Revenue 569.3 562.3 1 1,130.2 1,115.2 1 2,240.9
Operative EBITDA 61.5 58.2 6 125.0 121.0 3 249.4
of which margin 10.8 10.3 - 11.1 10.8 - 11.1
Operative EBIT 40.0 36.0 11 82.2 74.6 10 155.5
of which margin 7.0 6.4 - 7.3 6.7 - 6.9
Share of profit or loss
of associates
0.1 5.8 - -1.1 16.6 - 11.2
Financing income and expenses -4.2 1.4 - -28.9 -8.9 - -15.7
Operative EPS, EUR 0.14 0.21 -33 0.31 0.41 -24 0.77
Operative ROCE* 10.4 10.5 - 10.4 10.5 - 10.0
Capital expenditure 30.9 51.0 -39 59.9 70.4 -15 134.1
Casf flow after investing
activities**
10.5 24.2 -57 200.4 16.1 - 71.8
Gearing, % at period-end 36 44 - 36 44 - 42
Personnel at period-end 4,664 5,181 -10 4,664 5,181 -10 4,857
*12-month rolling average
**2012 numbers include EUR 5.3 million dividends and EUR 27.3 million paid-in-capital from JV Sachtleben. 1-6/2013 numbers include EUR 97.5 million received from the
divestment of the JV Sachtleben shares and EUR 80.6 million from the divestment of the food and pharmaceuticals businesses.
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 19

20. 2013
Revenue (local currencies
and excl. divestments)
2014 2016
Operative EBIT
0%-5% growth vs 2012
EBIT margin 10%
Revenue
EBITDA margin
Gearing
EUR 2.6 – 2.7 billion
15%
below 60%
increase >15% vs 2012
Outlook for 2013 and financial targets for 2014 and
2016 unchanged
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 20

21. Kemira Capital Markets Day
Tuesday 10 September 2013 in London,
UK (London Stock Exchange)
12.00 Lunch and registration
12.30 Presentations
• From redesign to expansion (Wolfgang
Büchele, President and CEO)
• M&I turnaround and efficiency improvements
(Frank Wegener, M&I and Michael
Löffelmann,
SVP restructuring and strategic projects)
• Innovation, incl. R&D showcases (Heidi
Fagerholm, CTO and R&D management)
15.30 Breakout meetings
• Four teams (CEO & CFO, Paper and APAC,
Oil & Mining and SA, M&I and efficiency)
18.00 Cocktails
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 21

23. Appendix
Kemira Interim report January-June 2013
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 23

24. Good balance between sales and raw material prices
Kemira sales prices vs variable costs
*) 12-month rolling change vs previous year, meur, excl. Tikkurila and Pigments
-150
-100
-50
0
50
100
150
200
Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
2007 2008 2009 2010 2011 2012 2013
Brent oil, USD Sales price* Variable costs*
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 24

25. YTD 2013 operative EBIT bridge
Kemira Group operative EBIT bridge, EUR million
0
10
20
30
40
50
60
70
80
90
100
YTD 2012 Sales volumes Sales prices Variable costs Fixed costs Currency impact Others, incl.
acquisitions and
divestments
Q2 2013
74.6 17.0 82.24.23.2-9.1 -5.7 -2.0
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 25

26. ”Fit for Growth” will improve EBIT
by EUR 60 million in 2014
• Cost savings impact in operative
EBIT in Q2 2013 was EUR 10 million
– EUR 4 million impacted variable costs
– EUR 6 million impacted fixed costs
• Expected cost savings impact in
operative EBIT 2013 is approximately
EUR 50 million
• Expected cost savings impact in
operative EBIT 2014 EUR 60 million
”Fit for Growth” status Q2 2013,
EUR million
50
60
10
19
0
10
20
30
40
50
60
70
Savings impact
2012
Savings impact
2013
Savings impact
2014
Expected savings Realized savings
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 26

27. ”Fit for Growth” required EUR 76 million
in restructuring costs
• EUR 5 million booked YTD 2013
• Total non-recurring severance payments and external services EUR 46 million
• Total non-recurring asset write-downs EUR 30 million
41
30
5
0
15
30
45
Severance payments and external services
2012
Asset write-downs 2012 Severance payments and external services
2013
Realized restructuring charges,
EUR million
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 27

28. Fixed costs are approximately 25%
of revenues
• Fixed costs include personnel
expenses, maintenance cost and leases
• Expected ”Fit for Growth” savings
approximately EUR 50 million in 2013
• Efficiency improvements and operating
leverage compensating the annual cost
inflation of around 3%
• TOP 10* raw materials account for
45% of raw material spend
Kemira cost breakdown
EUR million
*) From 1 to 10: Acrylic Acid, Cationic monomer, Acrylonitrile, Fatty acid, Petroleum solvents, Propionic acid, Aluminium Hydrate, Sodium hydroxide, Sulphuric acid, Hydrochloric acid
0
250
500
750
1,000
1,250
1,500
1,750
2,000
2010 2011 2012
Raw materials Logistics Energy Fixed costs
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 28

29. Cash flow statement
EUR million Q2 2013 Q2 2012 1-6/2013 1-6/2012 FY 2012
Operative EBITDA 61.5 58.2 125.0 121.0 249.4
Change in net working capital -6.8 -0.6 -11.1 -43.2 -21.1
Cash flow from operations* 38.6 47.5 78.9 57.9 176.3
Capital expenditure -30.9 -51.0 -59.9 -70.4 -134.1
Other investing activities 2.8 27.7 181.4 28.6 29.6
Cash flow after investing activities* 10.5 24.2 200.4 16.1 71.8
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 29
*2012 numbers include EUR 5.3 million dividends and EUR 27.3 million paid-in-capital from JV Sachtleben. 1-6/2013 numbers include EUR 97.5 million
received from the divestment of the JV Sachtleben shares and EUR 80.6 million from the divestment of the food and pharmaceuticals businesses.

30. Market and
product
specifications
Kemira Interim report January-June 2013
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 30

31. 1.5 1.7 1.9 2.0 2.1 2.2
0.9
1.0
1.1
1.8
2.0
2.3
1.5
1.6
1.8
2012 2016 2020 2012 2016 2020
Defoamers, biocides and other wet-end process chemicals
Paper segment - Demand for sizing and strength
chemicals is growing fastest globally
Pulp and paper industry trends increasing
chemical demand:
• Increased use of recycled fibres
• Hardwood replacing softwood in virgin
pulp
• Lightweighting of packaging and board
grades
• Higher filler loads in graphic papers
• New digital printing methods
• Lower water / energy consumption
Market size,
EUR billion (CAGR: 2.4%)
GAGR
Sizing and strength
Miscellaneous commodity chemicals
Bleaching chemicals
Polymers
3.5%
2.0%
3.0%
1.3%
2.0%
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 31

32. Paper segment - Technology and market leader in paper
wet-end chemistry
Value chain part covered by Kemira
RAW
MATERIALS
INTERMEDIATES PRODUCTS APPLICATIONS
CUSTOMER
IDUSTRIES
CUSTOMERS
Electricity
Sodium chloride
(salt)
Crude tall oil
Cationic monomer
Acrylonitrile
Acrylic acid
Olefins
Fatty acids
Maleic anhydride
Sulfur
Tall oil rosin
AKD Wax
Isomerized olefins
Acrylamide
Sodium chlorate
Hydrogen peroxide
Polymers
Defoamers
Coagulants
Biocides
Sizing
Strength Additives
Surface additives
Colorants
Sulfuric acid
Pulping
Bleaching
Retention
Wet-end process
control
WQQM
Sizing
Strength
Surface treatment
Coloring
Pulp
Packaging
and board
Printing
and writing
Tissue
All the major
global paper
and pulp
producers
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 32

33. Oil & Mining segment - Strong market growth across all
product lines
• High oil price spurs demand for
identifying new sources
• Global growth of shale gas and wet
shale
• Declining ore assays require improved
processing
• Increasing environmental pressure
which increases demand for waste
water treatment
Market size,
EUR billion (CAGR: 4.7%)
3.1 3.6 4.3
2.0 2.4 2.9
4.3
5.1
6.1
2012 2016 2020 2012 2016 2020
Polymers Defoamers, biocides
and other process
chemicals
Miscellaneous
commodity
products
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 33

34. Oil & Mining segment - Winning market share with
competitive combination of innovation chemicals and
application knowledge
Value chain part covered by Kemira
RAW
MATERIALS
INTERMEDIATES PRODUCTS APPLICATIONS CUSTOMERS
Acrylonitrile
Acrylic acid
Various monomers
Miscellaneous
specialty chemicals
and commodities
Acrylamide Polymers
Dispersants &
Antiscalants
Biocides
Emulsifiers
Defoamers
Coagulants
Formulations
Friction Reduction
Formation & Well Scale
Control
Asset integrity Microbial
Induced Corrosion
Enhanced Oil Recovery
Drilling muds
Concentrate thickening
Mineral slurry
preservation
Mining processes
Scale Control
Pumpers
Oil & Gas
operators
Service
companies
Mine operators
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 34

35. Municipal & Industrial - Commodity product lines expected
to grow, but slightly slower than the market
Demand drivers for raw and waste water as well as sludge treatment chemicals:
• Legislation and regulatory enforcements determine required treated water and
sludge quality standards
• Water reuse is most cost efficient solution to meet the increasing water demand
2.6 3.0 3.4
1.6 1.8 1.9
3.4
3.8
4.4
2012 2016 2020 GAGR
Coagulants Antiscalants, biocides, defoamers, miscellaneous commodity chemicals
3.2%
2.8%
3.3%
Polymers
Realized restructuring charges,
EUR billion
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 35

36. Municipal & Industrial - Technology and market leader in
raw and waste water as well as sludge treatment
• Kemira is the only major supplier producing major water treatment chemicals, polymers and coagulants – thereby
enabling comprehensive application support
• Cost competitiveness through backward integration into virgin raw materials
• 60-70% of sourced raw materials are recycled utilizing waste streams from industrial producers, providing an
additional cost advantage
RAW
MATERIALS
INTERMEDIATES PRODUCTS APPLICATIONS SALES CHANNEL CUSTOMERS
Acrylonitrile
Sulfuric acid
Hydrochloric acid
Aluminium hydrate
Iron ore
Pickling liquor
Copperas
Acrylamide Polymers
(EPAM, DPAM)
Al Coagulants
Fe Coagulants
Antiscalants
Biocides
Defoamers
Raw water
treatment
Wastewater
treatment
Sludge treatment
Advanced
water treatment
Direct sales
Distributor/reseller
Service companies
Municipalities
Private
operators
Industrial
customers
Value chain part covered by Kemira
23 July 2013Kemira Interim report Q2 2013, Wolfgang Büchele 36